ERBB2 and breast carcinoma: Furthermore, subtype analysis of breast cancer brain metastasis (BCBM) patients showed that HER2-enriched breast cancer and triple-negative breast cancer (TNBC) subtypes have a higher potential to develop brain metastasis, underscoring the particular importance of studying BCBM in these two subtypes of breast cancer (3).